Evidence map›Paper›PMID 24461581›Full record

ArticleThe Journal of allergy and clinical immunology2014

Mechanisms of vitamin D₃ metabolite repression of IgE-dependent mast cell activation.

Kwok-Ho Yip, Natasha Kolesnikoff, Chunping Yu, Nicholas Hauschild, Houng Taing, Lisa Biggs, David Goltzman, Philip A Gregory, Paul H Anderson, Michael S Samuel and 3 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Vitamin D and allergic diseases.Frontiers in immunology · 2024
    Review
  12. Review
  13. Review
  14. The Role of Vitamins in the Pathogenesis of Asthma.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Review
  17. Successful Treatment of a Patient With Severe COVID-19 Using an Integrated Approach Addressing Mast Cells and Their Mediators.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  18. Review
  19. Vitamin D, infections and immunity.Reviews in endocrine & metabolic disorders · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Kwok-Ho YipDivision of Human Immunology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia.
Natasha KolesnikoffDivision of Human Immunology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia.
Chunping YuDivision of Human Immunology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia; University of Adelaide, Adelaide, Australia.
Nicholas HauschildDivision of Human Immunology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia.
Houng TaingDivision of Human Immunology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia; University of Adelaide, Adelaide, Australia.
Lisa BiggsDivision of Human Immunology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia.
David GoltzmanDepartments of Medicine and Physiology, McGill University, Montreal, Quebec, Canada.
Philip A GregoryDivision of Human Immunology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia.
Paul H AndersonUniversity of South Australia, Adelaide, Australia.
Michael S SamuelDivision of Human Immunology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia; University of Adelaide, Adelaide, Australia; University of South Australia, Adelaide, Australia.
Stephen J GalliDepartments of Pathology and of Microbiology and Immunology, Stanford University School of Medicine, Stanford, Calif.
Angel F LopezDivision of Human Immunology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia; University of Adelaide, Adelaide, Australia; University of South Australia, Adelaide, Australia.
Michele A GrimbaldestonDivision of Human Immunology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia; University of Adelaide, Adelaide, Australia; University of South Australia, Adelaide, Australia. Electronic address: michele.grimbaldeston@health.sa.gov.au.
Centre for Cancer Biology · AUSouth Australia Pathology · AUUniversity of South Australia · AUMcGill University · CAStanford University · USUniversity of Adelaide · AU

Funding

Role of Mast Cells in Inflammation and ImmunityR01CA072074 · NCI · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 1996 to 2010
$4.4M
Expression and Modulation of Mast Cell Function in AsthmaR01AI070813 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 2006 to 2010
$2.5M
Regulation of Mast Cell Development and FunctionR01AI023990 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 1986 to 2010
$2.4M
REGULATION OF MAST CELL DEVELOPMENT &FUNCTIONR37AI023990 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN J · 1996 to 2005
$2.2M
CIHRNCI NIH HHS CA072074NCI NIH HHS R01 CA072074NIAID NIH HHS AI023990NIAID NIH HHS AI070813NIAID NIH HHS R01 AI023990NIAID NIH HHS R01 AI070813NIAID NIH HHS R37 AI023990
6 · The paper itself

Abstract

backgroundMast cells have gained notoriety based on their detrimental contributions to IgE-mediated allergic disorders. Although mast cells express the vitamin D receptor (VDR), it is not clear to what extent 1α,25-dihydroxyvitamin D3 (1α,25[OH]2D3) or its predominant inactive precursor metabolite in the circulation, 25-hydroxyvitamin D3 (25OHD3), can influence IgE-mediated mast cell activation and passive cutaneous anaphylaxis (PCA) in vivo.

objectiveWe sought to assess whether the vitamin D3 metabolites 25OHD3 and 1α,25(OH)2D3 can repress IgE-dependent mast cell activation through mast cell-25-hydroxyvitamin D-1α-hydroxylase (CYP27B1) and mast cell-VDR activity.

methodsWe measured the extent of vitamin D3 suppression of IgE-mediated mast cell degranulation and mediator production in vitro, as well as the vitamin D3-induced curtailment of PCA responses in WBB6F1-Kit(W/W-v) or C57BL/6J-Kit(W-sh/W-sh) mice engrafted with mast cells that did or did not express VDR or CYP27B1.

resultsHere we show that mouse and human mast cells can convert 25OHD3 to 1α,25(OH)2D3 through CYP27B1 activity and that both of these vitamin D3 metabolites suppressed IgE-induced mast cell-derived proinflammatory and vasodilatory mediator production in a VDR-dependent manner in vitro. Furthermore, epicutaneously applied vitamin D3 metabolites significantly reduced the magnitude of skin swelling associated with IgE-mediated PCA reactions in vivo; a response that required functional mast cell-VDRs and mast cell-CYP27B1.

conclusionTaken together, our findings provide a mechanistic explanation for the anti-inflammatory effects of vitamin D3 on mast cell function by demonstrating that mast cells can actively metabolize 25OHD3 to dampen IgE-mediated mast cell activation in vitro and in vivo.

Indexed as

25-Hydroxyvitamin D3 1-alpha-HydroxylaseAnaphylaxisAnimalsCalcifediolCell LineDermatitis, AtopicHumansImmunoglobulin EMast CellsMiceMice, KnockoutReceptors, Calcitriol25-Hydroxyvitamin D3 1-alpha-HydroxylaseCalcifediolImmunoglobulin EReceptors, CalcitriolanaphylaxisCYP27B1IgEinflammationMast cellsvitamin D(3)vitamin D receptor

Identifiers

PMID24461581
PMCPMC4154631
OpenAlexW2116518214

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.